Kenneth Lee Hopkins, NP | |
Psc 827, Box 119, Fpo, AE 09617 | |
(011) 390-818116263 | |
Not Available |
Full Name | Kenneth Lee Hopkins |
---|---|
Gender | Male |
Speciality | Nurse Practitioner - Family |
Location | Psc 827, Fpo, Armed Forces Europe |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1730489857 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | 20256 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Kenneth Lee Hopkins, NP Psc 827, Box 119, Fpo, AE 09617 Ph: (011) 390-818116263 | Kenneth Lee Hopkins, NP Psc 827, Box 119, Fpo, AE 09617 Ph: (011) 390-818116263 |
News Archive
New data released today at the annual meeting of the American Psychiatric Association show that the NeuroStar TMS Therapy System induced statistically and clinically meaningful response and remission in patients with Major Depressive Disorder during the acute phase of therapy, which were maintained through one year of treatment.
Among patients with the lung disorder non-cystic fibrosis bronchiectasis, treatment with the antibiotic erythromycin resulted in improvement in symptoms but also increased the risk of antibiotic resistance, according to a study appearing in the March 27 issue of JAMA.
A human infective nematode found in remote northern areas of Australia has been identified in canine carriers for the first time.
A research team, co-headed by Dr. Woo Lee and Dr. Hongjun Wang of Stevens Institute of Technology, has published a paper describing a new method that generates three-dimensional tissue models for studying bacterial infection of orthopedic implants. Dr. Joung-Hyun Lee of Stevens, and Dr. Jeffrey Kaplan of the New Jersey Dental School, are co-authors of the research.
Genomic Health, Inc. today announced worldwide commercial availability of its Oncotype DX® colon cancer test, the first multigene expression test developed for the assessment of risk of recurrence in patients with stage II disease. The 12-gene advanced diagnostic test is clinically validated to predict individual recurrence risk in stage II colon cancer patients following surgery, as reported at the 2009 American Society of Clinical Oncology (ASCO) meeting.
› Verified 2 days ago
Kathleen Nicole Dawood, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Sigonella Us Naval Hospital, Building #273, Fpo, AE 09636 Phone: 757-635-7624 | |
Mrs. Sondra Michelle Santana, ANP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: Uss Enterprise Cvn 65, Medical Department, Box 47, Fpo, AE 09543 Phone: 757-534-3778 | |
Dr. Terri Collins, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: Psc 836 Box 2670, Fpo, AE 09636 Phone: 011-390-9556 | |
Ms. Heather Ann Shattuck, ACNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Psc 836 Box 2670, Fpo, AE 09636 Phone: 348-719-7007 |